Noida, India, February 13, 2010 --(PR.com
)-- Vaccines have emerged as one of the most lucrative segment in the global pharmaceutical industry. With a projected CAGR of over 13% during 2009-2012, the industry will emerge as the fastest growing therapy area. The US and Europe represent the two largest vaccine markets in the world and will continue experiencing healthy growth rate in future.
As per their research "Global Vaccine Market Forecast to 2012”, the segment of pediatric vaccines presently dominates the global vaccine market; however, adult vaccine segments will define the future growth directions. The cancer vaccine market, led by cervical cancer vaccines, is presently one of the most lucrative areas for vaccine manufacturers.
Owing to lower margins and the mature nature of these markets, the basic and enhanced pediatric markets are expected to show insignificant growth in future. On the other hand, launch of a number of new vaccines will make the addiction, cancer and proprietary pediatrics/adolescent vaccine market highly dynamic. On a whole, the global vaccine market is expected to register revenues in excess of US$ 34 Billion by 2012.
Their analysis of the competitive landscape of the global vaccine market shows a highly concentrated structure, with the top four players accounting for around 74% of the total market in 2008.
Their report gives an extensive and objective analysis on the global vaccine market. It investigates both the past and current trends in the vaccine market, and outlines the future trends shaping the industry. It comprehensively assesses the performance of vaccines, both in the market as well as in the developing stage. Based on various present and future indicators, the report evaluates the prospects of various vaccine segments. The report can, thus, prove critical to manufacturers/investors preparing to enter the vaccine market.
The report includes forecast till 2012 on:
- Global Vaccine Revenues
- Basic Pediatrics Vaccine Revenues
- Enhanced Pediatrics Vaccine Revenues
- Proprietary Pediatrics/Adolescent Vaccine Revenues
- Adult Vaccine Revenues
- Influenza Vaccine Revenues
- Cancer Vaccines Revenues
- Share of Key Players in Vaccine Market
- Revenues of Key Vaccine Brands
A section on the market landscape has also been included in the report to give a category-wise overview of the key players, including Sanofi-Aventis, GlaxoSmithKline, Merk & Co., Inc, Novartis and Wyeth, operating in the global vaccine market.
For Free Sample of this report visit: http://www.rncos.com/Report/IM153.htm
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.